+(34) 91 129 3151
Viviabiotech
  • Cancer Research
    • Overview. What do we offer?
    • Ex vivo assays for Hematologic Malignancies
      • Overview
      • Cytotoxic Drugs Assays
      • Antiproliferative Drugs Testing
        • AML
        • CLL
        • MM
      • Complement-Dependent Cytotoxicity Assay (CDC)
      • Antibody-Dependent Cellular Cytotoxicity Assay (ADCC)
      • Bispecific Antibodies Testing
      • Immune Oncology Drugs Testing
      • Hematotoxicity Assay
      • Differentiation Assay
      • MRD+ Cells Assay
      • Targeted Drugs Testing
      • CART Cells Assays
      • Custom Assays
    • 3D Cultures Solid Tumor Assays
      • Overview
      • Cytotoxic Compounds Testing
      • Antiproliferative Drugs Testing
      • Bispecific Antibodies Testing
      • Migration and Invasion Assays
      • Immune Oncology Drugs Testing
      • Targeted Drugs Testing
      • Autologous TILs Expansion
      • Custom Assays
    • Molecular Biology
      • Overview
      • Combined Functional and Molecular Studies
      • NGS methods
    • Bioinformatic Analysis
      • Overview
      • Compound Profiling by Flow Cytometry
      • Data Analysis for Molecular Biology Assays
      • Advanced Analysis and Visualization through TIBCO Spotfire
    • Primary samples repository
    • Biomarker Discovery and CDx
  • Our Value
    • Overview
    • Our Experience
    • Projects Management
    • Regulatory Compliance
    • Our Team
  • Precision Medicine
    • Overview
    • PharmaFlow PM Test
    • Personalized Cancer Treatments
  • Resources
    • Overview
    • Scientific Publications
    • News
    • Brochures
  • Contact Us
    • Log In
    • Register
Brochures
Everything you need to be sucessful with Vivia Biotech in one handy place

AML Assays in Primary Patient Samples

Vivia Biotech can significantly enhance AML drug profiling processes thanks to our access to biological samples from real patients...

CDx Clinical Trials

An Innovative Biomarker‑Driven Design to Select Patient Population Upfront

T Cell Engagers in Primary Patient Samples

Hematotoxicity and Selectivity Assays

Primary Patient Samples for Hematology-Oncology Research

Proliferation Assays in Hematological Patient Samples

3D TME-Aligned Assays for Small Molecule Immunotherapies

3D TME-Aligned Assays for Immune Check Point Inhibitors (IChP), Mono and Multispecific

TME-aligned 3D Solid Tumor Models for Bispecific Antibodies

Innovative Drug Interaction Studies

Therapeutic window assays for NK-engagers: Killing activity tumor cells vs progenitors

Complement-Dependent Cytotoxicity (CDC) ex vivo Activity Assays at Physiological Levels

Vivia Experts in NK-Engager ex vivo Assays

Discovery Assay to Select Best Bispecific Antibodies Formats

T-Cell Therapy: Activated T Cells (CART and TILs) show killing activity against tumoral cells

TME-Aligned Model: Immuno-Oncology 3D Tumor Cell Killing by T-Cells Assay

more about resources

  • Scientific Publications
  • News
Click Here
  • Cancer Research
  • Ex vivo assays for Hematologic Malignancies
  • 3D Cultures Solid Tumor Assays
  • Molecular Biology
  • Bioinformatic Analysis
  • Primary samples repository
  • Biomarker Discovery and CDx
  • Our Value
  • Our Experience
  • Projects Management
  • Regulatory Compliance
  • Our Team
  • Precision Medicine
  • PharmaFlow PM Test
  • Personalized Cancer Treatments
  • Resources
  • Scientific Publications
  • News


Log In
Privacy Policy - Work With Us - Contact Us
2022 Vivia Biotech S.L. - All Rights Reserved
Reproduction of any materials from the website is forbidden without our permission